Table 5.
Serum lipid (cholesterol and TG) and liver enzymes (ALT, ALP, and AST) profiles of normal, untreated diabetic, metformin-treated diabetic and FFP-supplemented diabetic mice after 6 weeks of duration
| Cholesterol (mmol/L) | TG (mmol/L) | ALT (U/L) | ALP (U/L) | AST (U/L) | |
|---|---|---|---|---|---|
| Normal | 2.52±0.08d | 1.35±0.06d | 69.30±8.68c | 49.33±1.41d | 167.66±18.92e |
| Untreated | 5.28±0.74b | 4.83±0.02a | 175.30±7.78a | 126.67±8.18a | 337.18±18.80a |
| Metformin | 4.59±0.03c | 2.76±0.04b | 81.25±4.95b | 88.00±4.14b | 253.76±15.22b,c |
| FFP0.1 | 5.74±0.32a | 1.92±0.01c | 73.25±5.44b,c | 73.33±3.94c | 299.76±17.57a,b |
| FFP1.0 | 4.77±0.29c | 1.20±0.06d | 70.35±3.80c | 56.00±5.66d | 213.50±14.00d |
Notes: Different superscript letters indicate a significant difference compared with the untreated diabetic group, p<0.05. FFP0.1 and FFP1.0 indicate 0.1 and 1.0 g, respectively, of FFP per kg of body weight.
Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; FFP, fermented food paste; TG, triglyceride.